Comprehensive Overview
ZIM Laboratories Limited has disclosed its FY26 financial results alongside the notice for its 42nd Annual General Meeting scheduled for June 29, 2026. The company reported standalone revenue of ₹37,048 lakhs and net profit of ₹597 lakhs, representing a significant decrease from the previous year's performance.
Financial Performance Analysis
Revenue and Profitability
- Revenue from operations stood at ₹37,048.15 lakhs in FY26 compared to ₹37,563.55 lakhs in FY25
- Net profit after tax decreased to ₹596.52 lakhs from ₹1,174.40 lakhs in the previous year
- Export revenue contributed ₹3,150 million (84% of total income), while domestic revenue accounted for ₹594 million (16%)
- R&D expenditure represented 8.3% of total operating income at ₹311 million
- Other income increased to ₹1,138.99 lakhs from ₹562.09 lakhs, primarily due to foreign exchange gains of ₹770.26 lakhs
Key Financial Metrics
- Earnings per share (basic and diluted) decreased to ₹1.22 from ₹2.41
- Current ratio improved to 1.36 times from 1.30 times
- Debt-equity ratio improved to 36% from 46%
- Return on equity decreased to 2.25% from 4.93%
Capital Structure and Borrowings
Borrowings Position
- Total borrowings: ₹12,298.39 lakhs (FY25: ₹11,216.55 lakhs)
- Non-current borrowings: ₹4,158.83 lakhs (FY25: ₹4,030.10 lakhs)
- Current borrowings: ₹8,139.56 lakhs (FY25: ₹7,186.45 lakhs)
Security Arrangements
- First charge on all present and future property, plant and equipment
- Second charge on all current assets on pari passu basis with consortium members
- Personal guarantee of Managing Director for all borrowings
- Total assets pledged: ₹40,500.14 lakhs (property ₹15,257.01 lakhs, current assets ₹25,243.13 lakhs)
42nd Annual General Meeting Details
Meeting Information
- Date: Monday, 29th June, 2026
- Time: 11:30 a.m. IST
- Mode: Video Conferencing (VC) / Other Audio-Visual Means (OAVM)
- Record Date Closure: Register of Members closed from June 23-29, 2026
Key Resolutions
Ordinary Business:
1. Adoption of Audited Standalone and Consolidated Financial Statements for FY 2025-26
2. Reappointment of Mr. Zulfiquar Kamal as Whole-time Director
Special Business:
3. Ratification of cost auditor remuneration of ₹5,50,000/- for FY 2026-27
4. Approval of remuneration for Dr. Anwar Daud (Managing Director) and Mr. Zulfiquar Kamal (Whole-time Director)
Assets and Investments
Property, Plant and Equipment
- Gross carrying amount: ₹26,267.38 lakhs (FY25: ₹24,975.85 lakhs)
- Net carrying amount: ₹15,637.38 lakhs (FY25: ₹15,828.14 lakhs)
- Additions during the year: ₹1,875.52 lakhs
Intangible Assets
- Gross carrying amount: ₹1,861.99 lakhs (FY25: ₹1,799.13 lakhs)
- Net carrying amount: ₹375.31 lakhs (FY25: ₹531.39 lakhs)
- Intangible assets under development: ₹3,064.36 lakhs (FY25: ₹2,161.15 lakhs) for product marketing authorizations
Subsidiary Investments
- Investment in subsidiaries: ₹1,760.56 lakhs (FY25: ₹1,298.90 lakhs)
- The company has investments in seven subsidiaries across UAE, India, Latvia, and Australia
Key Audit Matters
The primary key audit matter focused on the 'Capitalization and realizability of Product Marketing Authorization Rights' due to material amounts (₹3,064.36 lakhs) and significant management judgement involved in assessing their realizability and useful life.
Compliance and Regulatory Framework
The documents confirm compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Companies Act, 2013, and various MCA and SEBI circulars. The financial statements were prepared in accordance with Indian Accounting Standards (Ind AS) and received an unmodified audit opinion from Deloitte Haskins & Sells LLP.
Voting and Shareholder Participation
- Remote e-voting available through NSDL platform from June 26-28, 2026
- Voting rights determined based on shareholding as of June 22, 2026 cut-off date
- Results will be declared post-meeting and published on company and NSDL websites